The most important financial indicators for the company A & B Pharma Srl - Unique Identification Number 8958182:
sales in 2023 was
134.732
euro, registering a net profit of
4.991
euro and having an average number of
2
employees.
Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.
Sales, Profit, Employees, Debts, Capitals, Financial Results -
A & B Pharma Srl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Sales - EUR
132.232
132.742
109.145
111.033
125.758
137.935
176.064
174.397
153.948
134.732
Total Income - EUR
132.232
132.755
109.145
111.125
125.758
137.935
176.064
174.397
153.948
135.267
Total Expenses - EUR
130.115
133.619
104.295
108.421
119.820
133.231
163.010
164.873
148.847
129.230
Gross Profit/Loss - EUR
2.117
-864
4.850
2.704
5.937
4.704
13.054
9.524
5.101
6.036
Net Profit/Loss - EUR
1.363
-2.018
4.058
1.569
4.680
3.529
11.952
8.264
3.905
4.991
Employees
3
2
3
3
2
3
3
4
3
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -12.2%, from 153.948 euro in the year 2022, to 134.732 euro in 2023.
The Net Profit increased by 1.098 euro, from 3.905 euro in 2022, to 4.991 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
A & B Pharma Srl - CUI 8958182
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
23.596
23.793
23.403
23.030
22.608
22.170
21.750
21.267
21.333
21.269
Current Assets
22.275
17.579
18.167
18.412
22.893
22.798
29.147
31.380
27.725
21.960
Inventories
19.750
7.522
7.902
8.737
11.264
12.499
13.445
15.676
16.930
17.127
Receivables
1.284
8.825
8.635
8.489
8.333
8.172
8.017
7.374
7.863
923
Cash
1.240
1.232
1.630
1.186
3.296
2.127
7.685
8.329
2.932
3.910
Shareholders Funds
11.012
7.235
11.220
12.598
17.047
16.919
23.110
25.329
17.360
14.459
Social Capital
67
67
67
66
64
63
62
61
61
61
Debts
34.858
34.137
30.350
28.844
28.453
28.049
27.787
27.318
31.698
28.770
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
21.960 euro in 2023 which includes Inventories of
17.127 euro, Receivables of
923 euro and cash availability of
3.910 euro.
The company's Equity was valued at
14.459 euro, while total Liabilities amounted to
28.770 euro.
Equity decreased by -2.848 euro, from 17.360 euro in 2022, to 14.459 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - A & B Pharma Srl